Prominent perikaryal expression of α- and β-synuclein in neurons of dorsal root ganglion and in medullary neurons

Experimental Neurology

Volumn 172, Issue 2, 2001, Pages 354-362

  Giasson, Benoit I ^a   Duda, John E ^a   Forman, Mark S ^a   Lee, Virginia M Y ^a   Trojanowski, John Q ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Dorsal root ganglion; Medulla oblongata; Parkinson's disease; Synuclein

Indexed keywords

ALPHA SYNUCLEIN; BETA SYNUCLEIN;

AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MEDULLA OBLONGATA; MOLECULAR CLONING; NERVE DEGENERATION; NERVE FIBER; NONHUMAN; PARKINSON DISEASE; PERIKARYON; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; SPINAL GANGLION; SYNAPTIC TRANSMISSION;

EID: 0035690513     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2001.7805     Document Type: Article

References (63)

1. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system
2. Peripheral nervous system-specific genes identified by subtractive cDNA cloning
3. Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein
4. NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy
5. Immunoelectron-microscopic demonstration of NACP/alpha-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies
6. Genetic analysis of familiés with Parkinson disease that carry the Ala53Thr mutation in the gene encoding alpha-synuclein
7. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies
8. Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores
9. Parkinson's disease-associated alpha-synuclein is more fibrillogenic than β-and γ-synuclein and cannot cross-seed its homologs
10. Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary
11. Persyn, a member of the synuclein family, influences neurofilament network integrity
12. Persyn, a member of the synuclein family, has a distinct pattern of expression in the developing nervous system
13. The synucleins: A family of proteins involved in synaptic function, plasticity, neurodegeneration and disease
14. Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited: NAC and alpha-synuclein are not associated with Abeta amyloid
15. Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions
16. A Drosophila model of Parkinson's disease
17. Differential expression and distribution of alpha-, beta-, and gamma-synuclein in the developing human substantia nigra
18. Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein
19. Rat alpha-synuclein interacts with Tat binding protein 1, a component of the 26S proteasomal complex
20. A panel of epitope-specific antibodies detects protein domains distributed throughout human alpha-synuclein in Lewy bodies of Parkinson's disease
21. A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly
22. Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro
23. Lewy bodies in Alzheimer's disease: A neuropathological review of 145 cases using alpha-synuclein immunohistochemistry
24. Alpha-synuclein promotes mitochondrial deficit and oxidative stress
25. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity
26. The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system
27. Identification of two distinct synucleins from human brain
28. Regulation of phospholipase D2: Selective inhibition of mammalian phospholipase D isoenzymes by a alpha- and beta-synucleins
29. Alpha-synuclein binds to Tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356
30. Axonal transport of synucleins is mediated by all rate components
31. Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing
32. Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation
33. Sensitization of neuronal cells to oxidative stress with mutated human alpha-synuclein
34. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease
35. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes
36. Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease
37. Reduced expression of the G209A alpha-synuclein allele in familial Parkinsonism
38. Synuclein: A neuron-specific protein localized to the nucleus and presynaptic nerve terminal
39. The rat brain synucleins: Family of proteins transiently associated with neuronal membrane
40. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: Implications for neurodegenerative disorders
41. Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons
42. Localization of phosphoneuroprotein 14 (PNP 14) and its mRNA expression in rat brain determined by immunocytochemistry and in situ hybridization
43. Distribution of phosphoneuroprotein 14 (PNP 14) in vertebrates: Its levels as determined by enzyme immunoassay
44. Alpha-synuclein shares physical and functional homology with 14-3-3 proteins
45. Mutated alpha-synuclein gene in two Greek kindreds with familial PD: Incomplete penetrance?
46. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease
47. Induction of neuronal death by alpha-synuclein
48. Cell and tissue distribution and developmental change of neuron specific 14 kDa protein (phosphoneuroprotein 14)
49. Chaperone-like activity of synucleins
50. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies
51. Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies
52. Alpha-synuclein in Lewy bodies
53. Synoretin: A new protein belonging to the synuclein family
54. Reduced neuritic outgrowth and cell adhesion in neuronal cells transfected with human alpha-synuclein
55. Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis
56. Chicken synucleins: Cloning and expression in the developing embryo
57. Distribution of tau proteins in the normal human central and peripheral nervous system
58. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein
59. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease
60. Neuropathology in mice expressing human alpha-synuclein
61. Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy
62. Delayed localization of synelfin (synuclein, NACP) to presynaptic terminals in cultured rat hippocampal neurons
63. Overexpression of human alpha-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells